OSN SuperSite - Preliminary analysis suggests anecortave acetate could
sustained IOP control
According to this review:
sustained IOP control
According to this review:
Open-angle glaucoma patients treated with a single sub-Tenon injection of anecortave acetate showed a significant, sustained reduction in IOP (average 7.2mmHg) over 3 months, according to an interim analysis of data from a clinical study.
No comments:
Post a Comment
Leave a Comment or Question: